Oprozomib is a proteasome inhibitor that inhibits the activity of the proteasome by blocking the targeted protein breakdown normally performed by the proteasome leading to the induction of programmed cancer cell death.
SparkCures ID | 63 |
---|---|
Developed By | Amgen |
Generic Name | Oprozomib |
Additional Names | ONX-0912 |
Treatment Classifications |
There are no resources, links or videos to display for this treatment.